← Back to Clinical Trials
Recruiting NCT07520487

NCT07520487 Effect of Intravenous Ketamine Combined With Spinal Anesthesia on Sensory Block Duration Compared to Spinal Anesthesia Alone in Lower Limb Surgeries in Geriatrics.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07520487
Status Recruiting
Phase
Sponsor Cairo University
Condition IV Ketamine With Spinal Block
Study Type INTERVENTIONAL
Enrollment 61 participants
Start Date 2026-04-25
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Patients will receive 0.2 mg/kg IV of ketamine diluted to 5 ml followed by infusion 0.1 mg/kg/hr as a 20 ml solutionPatients will receive 5 ml of saline followed by infusion 0.1 ml/kg/hr as a 20 ml solution as a control group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 61 participants in total. It began in 2026-04-25 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Effect of Intravenous Ketamine combined with Spinal Anesthesia on Sensory Block Duration compared to Spinal Anesthesia alone in Lower Limb surgeries in geriatrics:

Eligibility Criteria

Inclusion Criteria: * Patients aged 65 years and older * Both sexes * American Society of Anesthesiologists (ASA) physical status I, II, III * Scheduled for elective lower limb surgeries under spinal anesthesia in supine position Exclusion Criteria: * Patient's refusal. * Pre-existing neurological disorders. * Coagulopathy (i.e., Platelets ≤ 60,000 and/or INR\> 1.5). * Localized infection at the site of needle insertion. * Known hypersensitivity or allergies to any of the used drugs

Frequently Asked Questions

Who can join the NCT07520487 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying IV Ketamine With Spinal Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07520487 currently recruiting?

Yes, NCT07520487 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.

Where is the NCT07520487 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07520487 clinical trial?

NCT07520487 is sponsored by Cairo University. The trial plans to enroll 61 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology